VBL Therapeutics announced that it will host a conference call and live audio webcast on Thursday, May 14, 2020 at 8:30am Eastern Time to report first quarter ended March 31, 2020 financial results and to provide a corporate update.
TEL AVIV, Israel, May 04, 2020 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced that it will host a conference call and live audio webcast on Thursday, May 14, 2020 at 8:30am Eastern Time to report first quarter ended March 31, 2020 financial results and to provide a corporate update.
| Thursday May 14th @ 8:30amET | ||
| From the US: | 877-407-9208 | |
| International: | 201-493-6784 | |
| Israel: | 1 809 406 247 | |
| Conference ID: | 13703295 | |
| Webcast: | https://edge.media-server.com/mmc/p/ubiyng5a | |
About VBL
Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for areas of unmet need in cancer and immune/inflammatory indications.
INVESTOR CONTACT:
Michael Rice
LifeSci Advisors, LLC
(646) 597-6979
